FDA NDC Directory · JSON-LD · Markdown

Tirosint

NDC 71858-0010 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namelevothyroxine sodium
Labeler / ManufacturerIBSA Pharma Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021924
Dosage form / routeCAPSULE · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (25 ug/1)
Marketing started20181201
Package count3

External sources

Source: openFDA. Public-domain (CC0).